🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "focused measures to tackle household expense pressures" in the forthcoming Budget.

Speaking to media outlets, she emphasized that reducing inflation is a collective task of both the administration and the central bank.

The UK's price growth is projected to be the most elevated among the G7 developed nations this year and next.

Potential Utility Bill Measures

Sources suggest the government could intervene to bring down utility costs, for instance by cutting the present 5% rate of VAT applied on energy.

An additional option is to cut some of the policy costs currently added to bills.

Budgetary Limitations and Analyst Predictions

The government will obtain the latest draft from the official forecaster, the OBR, on the start of the week, which will show how much scope there is for these measures.

The consensus from most analysts is that the Chancellor will have to introduce tax rises or budget cuts in order to adhere to her self-imposed debt limits.

Previously on Thursday, calculations showed there was a twenty-two billion pound gap for the Treasury chief to fill, which is at the more modest range of projections.

"It is a collective task between the Bank of England and the government to further reduce some of the sources of inflation," Reeves stated to reporters in Washington, at the annual meetings of the IMF and global financial institution.

Tax Commitments and International Concerns

While much of the attention has been on likely tax rises, the chancellor said the most recent information from the OBR had not changed her pledge to campaign commitments not to increase rates on earnings tax, sales tax or National Insurance.

She attributed an "unpredictable global environment" with increasing international and trade issues for the Budget tax moves, probably to be focused on those "most able to pay."

Global Trade Tensions

Commenting on apprehensions about the UK's commercial links with the Asian nation she said: "The UK's security interests invariably are paramount."

Last week's announcement by China to increase export controls on rare earths and other materials that are crucial for advanced tech production led US President Donald Trump to threaten an extra 100% tariff on imports from China, raising the possibility of an full-scale trade war between the two global powers.

The US Treasury Secretary described China's move "commercial pressure" and "a international production power grab."

Asked about accepting the US offer to join its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the international commerce and creates additional challenges."

"In my view there are sectors where we must address Chinese policies, but there are also important chances to export to Chinese markets, including financial services and other sectors of the economic system. We've got to get that equilibrium correct."

The Treasury chief also stated she was cooperating with other major economies "regarding our own essential resources strategy, so that we are more independent."

Health Service Medicine Costs and Funding

The Chancellor also admitted that the cost the National Health Service spends on pharmaceuticals could increase as a result of ongoing discussions with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either halting or scrapping projects in the UK, with several attributing the insufficient payments they are receiving.

Last month, the Science Minister said the price the health service spends on medicines would must rise to stop firms and drug research funding leaving the United Kingdom.

The Chancellor told the BBC: "It has been observed as a result of the pricing regime, that drug testing, new drugs have not been offered in the UK in the extent that they are in other EU nations."

"The objective is to make sure that patients getting treatment from the National Health Service are able to access the best critical drugs in the globe. And so we are reviewing these issues, and... aiming to obtain additional investment into the UK."